Phase
Condition
Hearing Impairment
Hearing Loss
Deafness
Treatment
Nucleus ABI541 Auditory Brainstem Implant
Clinical Study ID
Ages 18-21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Group 1: Prelinguistic hearing loss (birth-5 years; age at implantation of ABI 18 months-5 years)
• Pre-linguistic hearing loss (birth-5 yrs.; age at ABI 18 months-5yrs) with both:
MRI +/- CT evidence of one of the following:
Cochlear nerve deficiency
Cochlear aplasia or severe hypoplasia
Severe inner ear malformation
Post-meningitis ossification
When a cochlea is present or patent, lack of significant benefit from CI despiteconsistent use (>6 mo.)
No or limited speech perception ability (limited to pattern perception onclosed set testing materials using the CI)
Lack of progress in auditory skills development
Group 2: Post-linguistic hearing loss (<21 yrs. of age)
Post-linguistic hearing loss (<21 yrs. of age) with:
Loss or lack of benefit from appropriate CI without the possibility forrevision or contralateral implantation. Examples might include:
Post-meningitis ossification
Bilateral temporal bone fractures with cochlear nerve avulsion
Failed revision CI without benefit
Previously developed open set speech perception and auditory-oral languageskills
No medical contraindications
Willing to receive the appropriate meningitis vaccinations
No or limited cognitive/developmental delays.
Strong family support
Reasonable expectations from parents/guardians including a thorough understanding:
of potential benefits and limitations of ABI
of parental role in rehabilitation
that the child may not develop spoken language as a primary communication modeor even sufficient spoken language to make significant academic progress in anaural/oral environment
Involvement in a rehabilitation program that emphasizes development of auditoryskills with or without the use of supplementary visual communication.
Able to comply with study requirements including travel to investigation sites.
Informed consent for the procedure from the child's parents/legal guardian.
Exclusion
Exclusion Criteria:
For both Groups 1 and 2:
Pre- or post-linguistic child currently making significant progress with CI Even forthe very young children (18 months of age with 6 months of use), nearly all childrenwith a good auditory signal from their CI will show evidence of improvement in thesemetrics over time.
MRI evidence of one of the following:
normal cochlea and cochlear nerves or NF2
brainstem or cortical anomaly that makes implantation unfeasible
Clear surgical reason for poor CI performance that can be remediated with revisionCI or contralateral surgery rather than ABI.
Intractable seizures or progressive, deteriorating neurological disorder
Patients with evidence of Chiari malformation, hydrocephalus, spina bifid a
Patients with any foreseeable need for a future MRI scan
Unable to participate in behavioral testing and mapping with their CI. If thisappears to be an age effect, ABI will be delayed until we can be assured that thechild will be able to participate, as reliable objective measures of mapping arecurrently not available for mapping these devices.
Unable to tolerate general anesthesia (cardiac, pulmonary, bleeding diathesis,etc.).
Need for brainstem irradiation
Unrealistic expectations on the part of the subject/family regarding the possiblebenefits, risks and limitations inherent to the procedure and ABI device.
Unwilling to sign the informed consent.
Unwilling to make necessary follow-up appointments.
Study Design
Study Description
Connect with a study center
NYU Cochlear Implant Center
New York, New York 10016
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.